Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Mersana Therapeutics
National Cancer Institute (NCI)
Genmab
AstraZeneca
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Exscientia AI Limited
M.D. Anderson Cancer Center
University of Washington
Seagen Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Avenzo Therapeutics, Inc.
Pfizer
SystImmune Inc.
Numab Therapeutics AG
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
Numab Therapeutics AG
Tempus AI
Pfizer
Northwestern University
Taproot Health
Mundipharma Research Limited
GOG Foundation
Mayo Clinic
M.D. Anderson Cancer Center
ADC Therapeutics S.A.
City of Hope Medical Center
Celldex Therapeutics
Gilead Sciences
pharmaand GmbH
Celldex Therapeutics
Eastern Cooperative Oncology Group
OHSU Knight Cancer Institute
Xencor, Inc.
Tesaro, Inc.
Xencor, Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
University of California, San Francisco
University Hospital Southampton NHS Foundation Trust
Mary Crowley Medical Research Center
GOG Foundation
AstraZeneca
Abramson Cancer Center at Penn Medicine